Categories: News

Zinzino AB (publ.): Interim Report for the third quarter of 2025

Strong sales growth and increased profit margins drive profitability upwards

GOTHENBURG, Sweden, Nov. 19, 2025 /PRNewswire/ — Revenue for the third quarter of 2025 amounted to SEK 784.1 (532.8) million, corresponding to 47% (22%) growth compared with the same period last year. In local currencies, revenue for the third quarter increased by 53% compared with the corresponding period last year. EBITDA increased to SEK 109.7 (63.0) million after the EBITDA margin increased to 14.0% (11.8%). The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.  During the quarter, Zinzino also acquired the assets of the US-based direct sales companies Bodē Pro and Truvy to increase distribution power in North America, Latin America, South Korea and Japan.

JULY-SEPTEMBER

  • Total revenue amounted to SEK 784.1 (532.8) million, corresponding to a growth of 47% (22%)
  • Gross profit amounted to SEK 277.2 (178.8) million and the gross profit margin was 35.4% (33.6%)
  • EBITDA amounted to SEK 109.7 (63.0) million and the EBITDA margin was 14.0% (11.8%)
  • Net profit amounted to SEK 89.4 (42.6) million
  • Net profit per share after tax before dilution amounted to SEK 2.47 (1.24)
  • Cash flow from operating activities amounted to SEK 136.6 (36.9) million

JANUARY-SEPTEMBER

  • Total revenue amounted to SEK 2,302.2 (1,494.3) million, corresponding to a growth of 54% (21%)
  • Gross profit amounted to SEK 748.7 (514.1) million and the gross profit margin was 32.5% (34.4%)
  • EBITDA amounted to SEK 268.2 (177.8) million and the EBITDA margin was 11.6% (11.9%)
  • Net profit amounted to SEK 200.9 (126.1) million
  • Net earnings per share after tax before dilution amounted to SEK 5.66 (3.69)
  • Cash flow from operating activities amounted to SEK 270.4 (128.3) million
  • Cash and cash equivalents on the balance sheet date amounted to SEK 529.2 (321.2) million

EVENTS AFTER THE REPORTING DATE

  • Acquisition of Sanki to increase distribution power in North America and South America
  • Acquisition of 35% of shares in Xion International Group
  • Launch of Gut Health Test

Link to the report:
https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/

For more information, please contact:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com

Images for free publication: marketing@zinzino.com

Certified Adviser: DNB Carnegie Investment Bank AB (publ.)

This information is information that Zinzino AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above at 10 AM CET on November 19, 2025.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab–publ–interim-report-for-the-third-quarter-of-2025,c4269392

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/zinzino-ab-publ-interim-report-for-the-third-quarter-of-2025-302619956.html

SOURCE Zinzino

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

24 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

1 day ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

1 day ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

1 day ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

1 day ago